1. Food and Drug Administration. Clinical outcome assessment qualification program: defining a clinical outcome assessment.
https://www.fda.gov/drugs/developmentapprovalprocess/drugdevelopmenttoolsqualificationprogram/ucm284077.htm
Accessed 4 June 2018.
2. Food and Drug Administration (2009). Guidance for industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. Federal Register, 74(35), 65132–65133
http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf
. Accessed 4 June 2018.
3. Food and Drug Administration. (2013). Roadmap to patient-focused outcome measurement in clinical trials.
https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm370177.htm
. Accessed 3 Jul 2018.
4. Food and Drug Administration. (2014). Guidance for Industry and FDA Staff: Qualification Process for Drug Development Tools.
https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/ucm335850.htm. Accessed 11 June 2018
.
5. Food and Drug Administration. (2018). Patient-focused drug development guidance: methods to identify what is important to patients and select, develop or modify fit-for-purpose clinical outcome assessments.
https://www.fda.gov/drugs/news-events-human-drugs/patient-focused-drug-development-guidance-methods-identify-what-important-patients-and-select
. Accessed 5 Jan 2020.